Showing results (641-650 of 1,156) with videos related to

Sort By:
Pageof 116
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 28, 2016
Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general populationAlberto Mazza, Salvatore Lenti, Laura Schiavon, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 2, 2017
Advances in radioguided surgery in oncologyRenato A Valdés Olmos, Sergi Vidal-Sicart, Gianpiero Manca, et al.
Clinical Nuclear Medicine|July 13, 2015
Clinical Usefulness of a Novel Freehand 3D Imaging Device for Radio-Guided Intraoperative Sentinel Lymph Node Detection in Malignant MelanomaLena Sulzbacher, Markus Klinger, Christine Scheurecker, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|June 15, 2019
Lymphoscintigraphy for the evaluation of limb lymphatic flow disorders: Report of technical procedural standards from an Italian Nuclear Medicine expert panelMarco Maccauro, Giuseppe Villa, Augusto Manzara, et al.
Insights Into Imaging|February 21, 2012
Imaging with non-FDG PET tracers: outlook for current clinical applicationsEgesta Lopci, Cristina Nanni, Paolo Castellucci, et al.
American Journal of Clinical Oncology|April 11, 2002
Radiotherapy alone in the treatment of clinical stage I-IIA, nonbulky, Hodgkin's disease: single-institution experience on 73 patients staged with lymphangiography and laparoscopyRenzo Mazzarotto, Caterina Boso, Giovanni Scarzello, et al.
Clinical Nuclear Medicine|December 11, 2013
Potential role of FDG PET/CT in evaluating patients with hepatic incidentalomasGaia Grassetto, Maria Cristina Marzola, Sotirios Chondrogiannis, et al.
Hellenic Journal of Nuclear Medicine|October 7, 2019
Utility of 18 F-FDG PET/CT in pre-surgical risk stratification of patients with breast cancerMudalsha Ravina, Babak Saboury, M S Chauhan, et al.
Journal of Alzheimer'S Disease : JAD|July 20, 2019
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative AnalysisMohsen Khosravi, Jonah Peter, Nancy A Wintering, et al.
Molecular Imaging and Biology|March 9, 2018
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast CancerKoosha Paydary, Siavash Mehdizadeh Seraj, Mahdi Zirakchian Zadeh, et al.
Pageof 116